Arkolith/Insider Trading/CLSD/Form 4

Thorp Clay

DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Dec 19, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 15, 2022Other(J)1.4M—$03.5M
Dec 15, 2022Other(J)9K—$017K

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-062045) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML